2023 WODC EU
30 October & 2 November in Barcelona, Spain
Join Worldwide Clinical Trials at WODC EU to network with colleagues, interact with key opinion leaders, and discuss strategies for operational success in clinical trials.
0
days leftAbout event
Our Rare Disease team combines deep scientific expertise with fresh perspectives on design and patient outreach—experts with decades of experience in the basics and the willingness to innovate to find a unique approach that will work for your program.
Our Derek Ansel, Executive Director, Therapeutic Strategy Lead, Rare Diseases, will be presenting Leveraging Genetics to Support Rare Disease Clinical Trials, on 31 October at 16:40 CEST.
If you are attending World Orphan Drug Congress EU, stop by booth 51 and say hello to our team.
Date
Monday to Wednesday
October 30 – November 2, 2023
Venue
Fira Barcelona Montjuic, Barcelona
Av. de la Reina Maria Cristina, s/n, 08004 Barcelona, Spain
Derek Ansel
Executive Director, Therapeutic Strategy Lead, Rare Diseases
Derek has worked in clinical research for more than a decade with a focus almost exclusively in rare and pediatric diseases, including non-malignant hematology, autoimmune diseases, metabolic disorders, movement disorders, and other genetic conditions. At Worldwide, he leads and supports corporate initiatives within rare and pediatric diseases and maintains relationships with over 60 patient-focused advocacy organizations. He holds a master’s degree in Pharmacology and Toxicology from Michigan State University and is pursuing a master’s degree in Genetic Counseling from Bay Path University.
